chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizzy, light headed, broke out in cold sweat, completely wet, weak, extremely, fever, dark stools & possible blood.
About 5 days after  second dose he developed a red rash.. blotchy.  Then a few days later  he was very weak, especially his hands and had difficulty swallowing.  Today the rash developed liquid filled pustules.
At almost 23 hrs post injection I had tingling down my entire Left Arm and lost ability to grasp and do fine motor skills with my thumb and first 2 fingers (pointer and middle). I also had difficulty rotating  my hand into a palm up position. It has gradually improved each day but I am now on day 4 post injection and I have to massage my arm, stretch my forearm and palm and still struggling grasping.  This was my booster shot and I receivers the J&J vaccine back in March 2021 with no reactions in March. I?m hopeful that I regain full mobility with my left hand and arm as it?s my dominate arm.
This spontaneous report was received from a pharmacist referring to an a unspecified number of patients of unknown age and gender. Medical history, concomitant medications and concomitant conditions were not reported. On an unspecified dates, the patients were vaccinated with improperly stored doses of ZOSTAVAX (dosage and route of administration were not provided; lot number L034736, expiration date 09-DEC-2016). No adverse effects were reported. The administered vaccines experienced a temperature excursion of 22F for 18 hours on an unspecified date. Data logger was not involved. Previous temperature excursion was 10F for 14 hours, 28F for 18 hours and 40F for 1 hour on an unspecified dates. A product quality complaint was not involved. Additional information has been requested.
Patient received expired dose of Pfizer COVID-19 vaccine that was meant to be given the day prior. The initial day the patient was supposed to receive the vaccine the nurse was not able to locate the dose that was to be given therefore the patient did receive his vaccine. The subsequent day a new order was placed for the same vaccine and as the pharmacist was delivering the new vaccine dose to the nurse to administer however the nurse found the previous day's dose and administered to the patient without notifying the pharmacist. The nurse was then re-educated on the beyond use date of vaccines (12 hours from the time the vaccine was drawn into syringe) and pharmacist reported this as a medication within the hospital's med-error reporting system. Pharmacist notified primary team that the patient received an expired dose of the vaccine and would need another dose. Pharmacist discussed with patient about the error that occurred and patient verbalized understanding and patient agreed to be re-vaccinated. Before patient could be vaccinated again the patient decided to hold off on getting a repeat dose of the vaccine. Within next 24 hours patient developed altered mental status and upon repeat head imaging he was shown to have worsening PML-IRIS  and was transferred to the ICU where he currently resides.
low grade fever, achy all over, joint discomfort, stomach ache, diarrhea,
Patient reports to clinic with a red, circular area surrounding the injection site. Presents with low grade fever and complains of burning sensation to that particular area. No C/P, SOB, abd. pain, N/V/D or s/s. TX: BACTRIM 40mg/200mg/5ml po (susp.). Take 15 ml bid po x 5 days. RTC in 2 days for recheck. Dx: cellulitis of upper (R) limb.
Slowly progressive tingling, imbalance, and mild weakness, with loss of reflexes, elevated CSF protein, and slightly elevated WBC in CSF. Current diagnosis is probable AIDP/GBS (Guillain Barre Syndrome) beginning about 12 days after vaccination.   EXAM: Mild weakness, imbalance, absent reflexes in legs, trace biceps reflexes
Patient felt fine immediately after vaccination, walked thru store w/family. At checkout register at front of the store became lightheaded and passed out.
The pt experienced diarrhea, huge hive on right size as big as an egg, bright red and swollen.
I had a continuous fever for over 24 hours with headaches, chills, and delirious thoughts. After 24 hours my temperature was 103 degrees Fahrenheit, so I went to the ER. They gave acetaminophen and another drug I forgot the name of and my fever went away.
This case was reported by a consumer via call center representative and described the occurrence of cardiac pain in a 56-year-old female patient who received SHINGRIX for prophylaxis. On 22nd April 2019, the patient received the 1st dose of SHINGRIX. In April 2019, less than a week after receiving SHINGRIX, the patient experienced cardiac pain (serious criteria GSK medically significant), heart fluttering (serious criteria GSK medically significant), autoimmune disorder (serious criteria GSK medically significant), fatigue and heartbeats increased. On 22nd April 2019, the patient experienced pain in arm, skin warm, chills and joint pain. On 23rd April 2019, the patient experienced arousal difficult (serious criteria GSK medically significant), headache and sleep excessive. On an unknown date, the outcome of the cardiac pain, heart fluttering, autoimmune disorder, arousal difficult, pain in arm, skin warm, chills, joint pain, headache, fatigue, sleep excessive and heartbeats increased were not recovered/not resolved. It was unknown if the reporter considered the cardiac pain, heart fluttering, autoimmune disorder, arousal difficult, pain in arm, skin warm, chills, joint pain, headache, fatigue, sleep excessive and heartbeats increased to be related to SHINGRIX. Additional details were provided as follows: The patient's symptoms started about 6 hours after SHINGRIX injection that she got about 5pm. The patient's arm became extremely sore, hot and then she got the chills with severe aches all in her joints. The patient slept on a heating pad to get through the night. The next day, the patient could not get up and slept most of the day still having trouble with achy joints and a headache. One week later, the patient at the time of reporting had headaches and achy joints with fatigue. The patient had been diagnosed with an autoimmune disease so she thought this would be helpful information. The other major symptom the patient had experienced was heart flutters that come and go. The patient's heart was fluttering, heart was floppy and uncomfortable, painful but not like ouch kind of thing. The patient had multiple ones not all the time but 1 or 2 times during the day. When describing her side-effects, she also said she was having some effects from it, over a week later, at the time of reporting. The patient continued to have rapid heartbeats several times through the day. The patient was recommended to speak with her healthcare provider regarding event. This case was linked with US2019AMR083807, reported for patient's husband.
Pt was given by error the adult dose of the hepatitis A vaccine instead of the pediatric dose, no treatment is needed and patient did well.
Chest tightest; She felt agitation; She felt spacey; Had anxiety; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST DISCOMFORT (Chest tightest), CONFUSIONAL STATE (She felt spacey), ANXIETY (Had anxiety) and AGITATION (She felt agitation) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced CONFUSIONAL STATE (She felt spacey) and ANXIETY (Had anxiety). On 04-Feb-2021, the patient experienced AGITATION (She felt agitation). On 14-Feb-2021, the patient experienced CHEST DISCOMFORT (Chest tightest). On 20-Feb-2021, CONFUSIONAL STATE (She felt spacey), ANXIETY (Had anxiety) and AGITATION (She felt agitation) had resolved. At the time of the report, CHEST DISCOMFORT (Chest tightest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
patient received the 1st dose / in 2019 / is late for the 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 87-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. No symptoms reported. The reporter consented to follow up.
"Moderna COVID-19 Vaccine EUA" Left arm was extremely sore soon after injection on Tuesday morning, couldn't reach behind back or lift above head without a lot of pain (4 days); felt tired that evening; woke up 4 times (!) during first night to empty bowels; chills and sweating during night (2 nights); headache in the morning (decided to take Tylenol); teeth hurting (dull pain off and on for 6 days); loss of appetite (3 days); diarrhea (second day); weight loss (4 lbs). Continued to take Tylenol and took time off from work, slept for most of the time and started feeling weak but better Thursday evening. Feel back to normal on Monday.
Patient received pneumonia (Pheumovax) in right arm on 10/22/09. Patient developed redness, swelling, cellulitis at the sight.  Patient was given Dynolmycin (antibiotic) to take. Patient is also diabetic.
Vaccinator was administering a child's Pfizer vaccine and forgot to dilute it with sodium chloride 0.9% first.
PT STATES BY 11PM AFTER VACCINATION HER ARM WAS HURTING AND BY 2AM SHE HAD DIFFICULTY LIFTING UP HER ARM. PAIN SHE DESCRIBES AS A SHARP PAIN. BY THE NEXT DAY, RANGE OF MOTION RETURNED BUT STILL HAS A DULL PAIN AT SITE OF INJECTION AND A LITTLE AROUND THE SURROUNDING AREA.
No adverse event occurred. Janssen is not currently indicated for under 18. She is 17. Her mother was present at the vaccination. We saw her again on 5/17/21 and there were no adverse events.
pt devel redness & tenderness @ inject site < 24 hrs p/vax; 48 hrs p/devel chest heaviness (lasted 3 wks-resolved w/o rx), dizziness (light-headed), felt feverish (temp not taken), cough & SOB; outpatient cardiac eval was neg;
Information has been received from a pharmacist, an adult female with a history of splenectomy at 28 years of age resulted from a car accident, who approximately in 1998 ("about 10 years ago") received the second dose of PNEUMOVAX 23 (lot number, route and injection site unknown). Subsequently the arm where she receiving the vaccine turned yellow, which looked like "jaundice of the arm". In an unspecified time period, her symptom resolved spontaneously. On 07-NOV-2008, she received her fourth dose of PNEUMOVAX 23 (lot number, route and injection site unknown), and subsequently experienced some redness and pain at the injection site which she still had at the time of reporting. The patient also reported that she had a total of 4 doses of PNEUMOVAX 23 administered every 5 years because she did not have a spleen. There were no problems with the first and third dose. She had sought medical attention in physician's office. Additional information has been requested.
Swelling of injection site, decreased ROM, pain, advancing to SOB and dizziness. Pt. c/o rt arm s/s as above.
Slight Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Slight Fever) and HEADACHE (Headache) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included RITUXIMAB (RITUXAN) for Rheumatoid arthritis.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Slight Fever) and HEADACHE (Headache). At the time of the report, PYREXIA (Slight Fever) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. Patient had received first dose of Moderna COVID-19 vaccine on 03-JAN-2021 or 04JAN-2021 . Patient had received Rituxan infusion 6 or 7 weeks before vaccination.   This case was linked to MOD-2021-265569 (Patient Link).
A 4-year-old male patient developed a rash at the puncture area 22 minutes after being vaccinated with his first dose of Moderna 6month-5y/o.
Swollen, itchy, hot, rash around injection site.  Motrin, antihistamine, cold pack.
This spontaneous report was received from the registered nurse regarding a 3 years old patient of unknown gender. The patient's medical history, concurrent conditions, drug allergies/reactions and concomitant medications were not provided. On 14-AUG-2018, the patient was vaccinated with improperly stored VARIVAX (product storage error) lot # N031001 and expiration date 03-NOV-2019 (doses, frequencies, routes were not provided) for prophylaxis which were reconstituted with a properly stored sterile diluent (unknown manufacturer) lot # M037021 with expiration date 04-MAY-2019. The vaccine was stored at a temperature of -9 degree Celsius to 8 degree Celsius, time frame of 2 hours and 15 minutes. The vaccine was also stored out of range at -6 degree Celsius for an approximate time of 15 minutes. There was no previous temperature excursion. Digital Data logger was involved. The date of VARIVAX storage error was 22-JUL-2018. No adverse events were reported. The outcome of the event product storage error and no adverse event were unknown. This is one of the several report received from same reporter. Sender's Comments: US-009507513-1807USA011693.
My period came two weeks early for the last two cycles. Once my period came it was extremely heavy and long for 9 days . I have never taken nor am I on Birth Control so this is strange. Further, this has never happen to me until  I took this vaccine.
shortness of breath; tachycardia; My hemoglobin dropped to 6.6; 24 hours after my second vaccine dose I started having a heavy period.; This is a spontaneous report from a contactable consumer (patient). A 43-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Ep6955, Expiry date: unknown), via an unspecified route of administration, administered in arm left on 27Mar2021 16:00 (at the age of 43-years-old) as dose 2, single for covid-19 immunisation. Medical history included hyperthyroidism. Concomitant medications included ethinylestradiol/ferrous fumarate/norethisterone acetate (LO LOESTRIN FE); methimazole (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN), all for an unspecified indication and from an unspecified date and unknown if ongoing. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number En6199, Expiry date: unknown) via an unspecified route of administration, administered in Left arm on 05Mar2021 17:45 (at the age of 43-years-old) as dose 1 for covid-19 immunisation. No known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Mar2021 16:00 24 hours after my second vaccine dose the patient experienced a heavy period. Not normal with the birth control she was taking because she would only spot monthly. The bleeding became so heavy that she was passing large clots and soaking through sanitary pads every 2 hours. She visited her Obgyn, and he stopped her birth control and prescribed a medication to stop the bleeding. This did not work. She went to ER with shortness of breath and tachycardia 6 days later. She lost 2 litres of blood. She required a d and c procedure. Her haemoglobin dropped to 6.6 and she received a blood transfusion. She spent 4 days in the hospital. She never had anything like this prior. The patient was hospitalized for shortness of breath and tachycardia for 4 days.  The patient underwent lab tests and procedures which included haemoglobin: 6.6 (haemoglobin dropped to 6.6) on 28Mar2021. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
According to Patient's son: Patient fell down after reaching home after getting this vaccine. Patient was admitted to ER same evening. According to ER doctor, patient has blood clot in his brain and is in vegetative state.
Large bullseye like rash on injection site (right deltoid) developed 1 week post vaccination. Then developed multiple red, itchy bumps on front and back of neck.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. A patient of unspecified age, gender and ethnicity received PREVNAR and PNEUMOVAX 23 on unspecified dates. The patient has an underlying lung disease. Concomitant medications were not reported. The physician reported that the patient continues to get pneumococcal pneumonia on unspecified dates. Therapeutic measures taken in response to the pneumococcal pneumonia are unknown. The clinical outcome of the pneumococcal pneumonia is unknown.
Having a hard time focusing on tasks; Muscle pain; Extreme fatigue; It's like a very bad flu.; This is a spontaneous report from a contactable consumer. A patient of an unknown age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 29Sep2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. On 30Sep2021 the patient experienced having a hard time focusing on tasks due to muscle pain and extreme fatigue, it was like a very bad flu. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events having a hard time focusing on tasks, muscle pain, extreme fatigue and it was like a very bad flu was unknown at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Generalized macular/papular rash on face, trunk, arms, and legs. Onset was 1-20-2007. Has just moved to Springfield from Indiana. Came to the local Health Department with symptoms.
This non-serious consumer report (initial receipt 06-OCT-2014) concerns a female patient. On an unknown date, the patient received an unspecified flu shot. On an unknown date, the patient experienced a negative reaction to the unspecified flu shot. She also reported that she also had an unspecified reaction to an unspecified "smallpox vaccine". Outcome was not reported.
a temperature of 102.7F; Not eating; sluggish; A spontaneous report was received from a consumer concerning an 81-year- old, female patient who experienced a temperature of 102.7F and sluggishness.    The patient's medical history was not provided.  Concomitant product use was not provided by the reporter.       On 21JAN2021, approximately 21hours prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number:032L20A) intramuscularly for prophylaxis of COVID-19 infection.   Patient's daughter stated that her mother received the first dose of the Moderna mRNA-1273 vaccine on 21Jan2021 around 4PM at the Health clinic. On 22JAN2021 Friday around 1PM patient's temperature rose to 102.7F and patient was not eating. Daughter was able to get patient's fever down by administering 1000mg of Tylenol. On the following morning, patient became sluggish and fever returned to 101.8F at 4PM. Patient's physician recommended the patient take 1G of Tylenol Q8H as needed. Patient received second dose of Tylenol on 23JAN2021.    Action taken with mRNA-1273 in response to the events was unknown.  The events, a temperature of 102.7F and sluggishness were considered recovering/resolving.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
experiencing shooting pains down my arm where I was vaccinated pain radiates into my shoulder and elbow; experiencing shooting pains down my arm where I was vaccinated pain radiates into my shoulder and elbow, Pain in hand; I feel tingles, burning, itching, and numbness; I feel tingles, burning, itching, and numbness; I feel tingles, burning, itching, and numbness; This also radiates into my hands and my face on the left side has also experienced some shooting pain and numbness; This also radiates into my hands and my face on the left side has also experienced some shooting pain and numbness; This also radiates into my hands and my face on the left side has also experienced some shooting pain and numbness; This also radiates into my hands and my face on the left side has also experienced some shooting pain and numbness; anxiety; My menstrual cycle was also been delayed for 14 days; pretty uncomfortable for me; This is a spontaneous report from a contactable Consumer or other non-health care professional (Patient).  A 22-Years-Old Non-pregnant Female received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and Batch no/Lot number: not reported) via an unspecified route of administration on an unknown date at the age of 22-years-old as dose 2, single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. No Known allergies were reported. Historical vaccine included patient took bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation:  solution for injection; Batch no/Lot number: not reported) via an unspecified route of administration, administered in left arm on 31Mar2021 03:00 PM (at the age of 22-years-old) as dose 1, single for COVID-19 immunization. Patient did not receive other vaccines within four weeks and No other medications received within two weeks of vaccination. Patient was not diagnosed with covid prior vaccination and not tested post vaccination. On 02Jun2021 at 10:00 AM, 6 weeks post 2nd vaccine patient has been experiencing shooting pains down her arm where she was vaccinated, pain radiates into her shoulder and elbow. She felt tingles, burning, itching, and numbness and also radiates into her hands and her face on the left side has also experienced some shooting pain and numbness. Patient thought some of that could be anxiety-induced but the arm issues are a bit concerning for her. It does come and go but it has been pretty uncomfortable for her. Her menstrual cycle was also been delayed for 14 days. But it did come. Events resulted in Doctor or other healthcare professional office/clinic visit. No treatment received for the events caused. Outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.